211 related articles for article (PubMed ID: 26087193)
21. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
Beuschlein F; Schulze E; Mora P; Gensheimer HP; Maser-Gluth C; Allolio B; Reincke M
J Clin Endocrinol Metab; 1998 Jul; 83(7):2585-8. PubMed ID: 9661649
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
23. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
[TBL] [Abstract][Full Text] [Related]
24. Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features.
Juhlin CC; Stenman A; Zedenius J
Histopathology; 2021 Oct; 79(4):661-666. PubMed ID: 34008223
[TBL] [Abstract][Full Text] [Related]
25. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.
Melo SA; Ropero S; Moutinho C; Aaltonen LA; Yamamoto H; Calin GA; Rossi S; Fernandez AF; Carneiro F; Oliveira C; Ferreira B; Liu CG; Villanueva A; Capella G; Schwartz S; Shiekhattar R; Esteller M
Nat Genet; 2009 Mar; 41(3):365-70. PubMed ID: 19219043
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
[TBL] [Abstract][Full Text] [Related]
27. Expression of p53 in adrenocortical tumours: clinicopathological correlations.
McNicol AM; Nolan CE; Struthers AJ; Farquharson MA; Hermans J; Haak HR
J Pathol; 1997 Feb; 181(2):146-52. PubMed ID: 9120717
[TBL] [Abstract][Full Text] [Related]
28. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
29. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
30. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms.
Erickson LA; Jin L; Sebo TJ; Lohse C; Pankratz VS; Kendrick ML; van Heerden JA; Thompson GB; Grant CS; Lloyd RV
Endocr Pathol; 2001; 12(4):429-35. PubMed ID: 11949624
[TBL] [Abstract][Full Text] [Related]
31. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
[TBL] [Abstract][Full Text] [Related]
32. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
[TBL] [Abstract][Full Text] [Related]
33. Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System.
Feinmesser M; Benbassat C; Meiri E; Benjamin H; Lebanony D; Lebenthal Y; de Vries L; Drozd T; Spector Y
Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):522-31. PubMed ID: 25265426
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas.
Mannelli M; Gelmini S; Arnaldi G; Becherini L; Bemporad D; Crescioli C; Pazzagli M; Mantero F; Serio M; Orlando C
J Clin Endocrinol Metab; 2000 Jan; 85(1):468-70. PubMed ID: 10634426
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
[TBL] [Abstract][Full Text] [Related]
36. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
Chabre O; Libé R; Assie G; Barreau O; Bertherat J; Bertagna X; Feige JJ; Cherradi N
Endocr Relat Cancer; 2013 Aug; 20(4):579-94. PubMed ID: 23756429
[TBL] [Abstract][Full Text] [Related]
37. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors.
Pereira SS; Costa MM; Guerreiro SG; Monteiro MP; Pignatelli D
Pathol Oncol Res; 2018 Jul; 24(3):689-693. PubMed ID: 28695321
[TBL] [Abstract][Full Text] [Related]
39. Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.
Ren W; Shen S; Sun Z; Shu P; Shen X; Bu C; Ai F; Zhang X; Tang A; Tian L; Li G; Li X; Ma J
Cancer Lett; 2016 Jun; 375(2):209-220. PubMed ID: 26965998
[TBL] [Abstract][Full Text] [Related]
40. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
